ThinkstockWith the markets making new highs seemingly every day, it is understandable that investors may be finding it harder and harder to find stocks that do not appear overvalued, or at a…
Short sellers may be getting smarter about all the inflows of capital heading into dividend stocks. The short interest fell in many of the names, but investors should understand that this short interest had…
Jon Ogg24/7 Wall St. wants some insight from readers ahead of earnings season. We have grouped four rival sectors to see which ones investors are more excited about this earnings season. This is…
ThinkstockAccording to the Center for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese. Obesity-related medical conditions include heart attack, stroke, type-2 diabetes and even…
Short sellers have kept their attack up against the high-dividend stocks, perhaps indicating that many investors believe that the bull market may turn back toward growth rather than paying a higher premium…
Short sellers have continued to by and large increase their short-sale bets against the quality high-yield dividend stocks. The price gains must lead short sellers to believe that the yields are getting…
U.S. equity markets opened lower this morning following news out of China that government is about to tighten restrictions on real estate transactions. The news pushed the Shanghai exchange down nearly 4%…
Jon OggThese are some of this Monday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) raised to Neutral at J.P. Morgan. AON Corp. (NYSE: AON)…
Jon OggShort sellers have increased their bets by and large against our universe of go-to quality dividend stocks. We tracked the short interest changes from the February 15 settlement date, versus the…
Short sellers have had their challenges due to rising share prices since the start of 2013. They have gone on to make some serious changes in the high dividend stocks now that…
ThinkstockInvesting in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited pipelines or their very survival depends on a single binary event that…
U.S. equity markets opened lower this morning as concerns about European markets reared up again. The U.K.’s PMI came in lower than expected and consumer confidence was lower, sending equities markets on…
Jon OggThese are this Monday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Broadcom Corp. (NASDAQ: BRCM) reiterated Buy with $46 target at Argus. Cavium Inc. (NASDAQ: CAVM) reiterated…
ThinkstockCorporate governance issues are sometimes a blessing for shareholders, but they also can crush the rights of shareholders in many cases. Tracking CEO pay of large public companies is now considered open hunting…
U.S. equity markets opened higher this morning on the heels of a solid report on U.S. nonfarm payrolls, which rose less than expected but on top of a large upward revision for…
